| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 69,132 | 59,568 | 58,694 | 60,563 | | Cost of Revenue | 44,518 | 39,718 | 40,116 | 41,441 | | | Gross Profit | 24,614 | 19,850 | 18,578 | 19,122 | | | Operating Expenses | | Research Development | 2,411 | 2,159 | 2,061 | 2,325 | | Selling General and Administrative | 14,000 | 12,897 | 12,416 | 13,372 | | Non Recurring | 22 | (311) | 289 |
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 8,181 | 5,105 | 3,812 | 3,425 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 421 | 265 | 604 | 465 | | Earnings Before Interest And Taxes | 8,602 | 5,370 | 4,416 | 3,890 | | Interest Expense | 153 | 107 | 109 | 129 | | Income Before Tax | 8,449 | 5,263 | 4,307 | 3,761 | | Income Tax Expense | 2,190 | 1,721 | 1,590 | 1,114 | | Minority Interest | 108 |
-
|
-
| (20) | | | | Net Income From Continuing Ops | 6,259 | 3,542 | 2,717 | 2,627 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| 134 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 6,367 | 3,542 | 2,717 | 2,761 | | Preferred Stock And Other Adjustments | (47) | 42 | 5 |
-
| | | Net Income Applicable To Common Shares | $6,320 | $3,584 | $2,722 | $2,761 |
|
0.29% Nasdaq 
0.11 (0.27%) 
Income Statement
